Division of Translational and Clinical Sciences DTCS
Review Branch:
Cancer Therapeutics CTH

Dr. Lambratu Rahman Sesay serves as Chief of the Cancer Therapeutics Review Branch (CTH RB).

Dr. Lambratu Rahman Sesay received her Ph.D. in biochemistry from Howard University in Washington, DC. Before coming to CSR, she was an intramural research training associate in the Molecular Therapeutics Program at the National Cancer Institute where her research focused on the role of thymidylate synthase in cellular transformation. Dr. Rahman Sesay has also served in the capacity of acting Chief of Oncology Translational Clinic before becoming Chief of BDA.


Last updated: 12/01/2023 14:24